Kelly Meza, Research Assistant at Dana-Farber Cancer Institute, shared a post on X:
“I had an incredible time hosting the Journal Club at BCM Department of Medicine, where we explored the fascinating RENOVE study recently published in The Lancet. We looked into the differences between low-dose and high-dose AC. Reduction of clinically relevant blood with low-dose AC.”
More posts featuring Kelly Meza.